Facial Nerve ParesisNCT05568108
Using the Masseteric Nerve for Facial Nerve Reanimation
An observational study of Facial Nerve Paresis, run by Assiut University at 1 site in Egypt.
Trial summary
The return of eyelid function and facial expression in Patients with facial nerve affection is very important for quality of life. Eyelid dysfunction leads to drying and ulceration of cornea which may lead to permanent vision loss. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Facial Nerve Paresis
- What is being tested?
- masseteric nerve to central branch facial nerve and Masseteric nerve to free functioning muscle transfer
- Type of treatment
- Surgery or procedure
- How many people
- 24 participants
- Where
- 1 siteEgypt
- Study dates
- 4 Nov 2020to 1 Apr 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Facial nerve affection patients
Who may be able to join
- Facial nerve affection
- Patients are generally fit with no other disease interfere with microsurgery.
- Electromyography showing fibrillations for group A and no fibrillation for group B.
Who cannot join
- Patient with other medical or mental disease-causing generalized paralysis.
- Syndromic cases.
- Patients are generally unfit or with any disease interfere with microsurgery.
Trial locations and contacts
1 site in 1 country.
Egypt1 site, 1 recruiting
- Recruiting
Plastic Surgery Department Assiut University
Asyut, 71511
Ahmed M refaat, MCCh
About this study
Official title: Using the Masseteric Nerve for Facial Nerve Reanimation: A Clinical Study.
The return of eyelid function and facial expression in Patients with facial nerve affection is very important for quality of life. Eyelid dysfunction leads to drying and ulceration of cornea which may lead to permanent vision loss.
Facial paralysis is distinguished into two main groups according to the presence or absence of facial fibrillations at needle Electromyography. Recent paralysis, mainly lasting less than two years generally show these signs and are eligible for reactivation of facial nerve by anastomosing it to a donor one (early facial reanimation).
The masseteric nerve (motor branch of trigeminal nerve ) is a reliable donor nerve on early facial reanimation So on this study we examine the advantages and disadvantages of using masseteric nerve to develop a protocol for use of facial reanimation and restoration of function on facial paresis.
Read the detailed description
Type of the study: observtional Study (clinical trial)
Intervention Model Description:
Patients will be two groups according to the surgical procedure performed as follows:
- Group A: masseteric nerve to central branch facial nerve. (Early fibrillation on EMG)
- Group B: Masseteric nerve to free functioning muscle transfer. (Late no fibrillation on EMG)
Allocation and Randomization:
Twenty-four patients will be assigned to Group A early or Group B late (2 groups). group A will be for early and be will be for late cases
Study Setting: Plastic and Reconstructive Surgery Department, Assuit University Hospital and San Paolo university hospital of Milano university.
Study subjects:
Inclusion criteria:
1.Facial nerve affection 2.Patients are generally fit with no other disease interfere with microsurgery. 3.Electromyography showing fibrillations for group A and no fibrillation for group B.
- Exclusion criteria:
1.Patient with other medical or mental disease-causing generalized paralysis. 2.Syndromic cases. 3.Patients are generally unfit or with any disease interfere with microsurgery.
- Sample Size Calculation: 24 Sample size was calculated using G power program version 3.1.9.4 (6) in order to detect a significant difference in mean of EFACE score (one of main assessed outcomes in the study ) between two groups under the study , assumed effect size 0.6 based on clinical assumption ( novel study ), α error 0.3 , power 0.80, and allocation ratio 1: 1.
Twenty-two patient plus 10% for dropouts to make total twenty-four (12 patient for every group).
Study tools
All patients in this study are subjected to:
Pre-operative Assessment:
- Patient history.
- All patients will do preoperative clinical and neurophysiological assessments of mimetic muscle function and donor nerve status (the ipsilateral deep temporal nerve. The neurophysiological tests will include needle Electromyography (EMG) for recruitment of residual motor unit action potential to determine which procedure
- The trigeminal motor component will be tested by palpating the temporalis muscle and masseteric muscle during chewing and via needle EMG to verify availability as a donor motor nerve.
- Photographic documentation preoperative using standardized EFACE view.
- Ophthalmological assessment of the affected eye for detection of redness, ulcer, etc.
Surgical procedure:
Group A the investigators will avoid the use of muscle relaxants to induce anaesthesia and employ an electro-stimulator to identify the masseteric nerve and the facial nerve branches supplying the affected side.
Exploration on the affected side a facelift-type incision will be performed, and an anterior subcutaneous flap is then will be lifted for several centimetres. In the inferior zygomatic region, the plane of elevation is deepened into the sub-SMAS plane and a composite flap elevated for several centimetres. Following elevation in this plane, the distal facial nerve branches will be identified. The distal portion of the zygomatic nerve is usually located midway between the oral commissure and the helical root. and was confirmed by nerve stimulator.
Then masseteric nerve identified in masseteric muscle and then end to end anastomosis with the central branch of facial nerve Then suction drain will be put and will be removed after 24 hours. Group B The same technique of face lift and harvest the free functioning muscle flap and micro anastomosis of the flap for the superficial temporal system or the facial artery system and the same technique for masseteric nerve identification and end to end anastomosis and to side for prepare cross nerve form the stage one Post-operative All patient will receive physiotherapy and post-operative follow up to detect any wound complication.
Evaluation (After 6 months from the operation)
- Photo documentation for EFACE
- Donor site morbidity.
- Onset of first movement
- Patient satisfaction
Complications:
- General surgical complication.
- General complication due to general anaesthesia.
- Specific complication:
- Delayed healing of nerve anastomosis.
- Affection of mastication.
- No postoperative improvement.
Research outcome measures:
- Primary (main): Comparing the outcomes on EFACE score
Secondary (subsidiary):
- Easy technique for rapid masseteric nerve identification.
- Effect of addition of contracted growth factor around the anastomosis
- Procedure-related morbidity and mortality.
- Effect of selective neurectomy for overactive affected branches with the total reanimation
- The experience of adding another neural impots with masseteric nerve
- Operative time and hospital stay.
- Conditions
- Facial Nerve Paresis
- Being tested
- masseteric nerve to central branch facial nerve, Masseteric nerve to free functioning muscle transfer
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
masseteric nerve to central branch facial nerveProcedure or surgery
masseteric nerve to central branch facial nerve. (Early fibrillation on EMG)
Masseteric nerve to free functioning muscle transferProcedure or surgery
Masseteric nerve to free functioning muscle transfer. (Late no fibrillation on EMG)
| Study group | Role | What they receive |
|---|---|---|
| nerve transfer | masseteric nerve to central branch facial nerve. (Early fibrillation on EMG) Receives: Procedure: masseteric nerve to central branch facial nerve | |
| nerve and free functioning muscle transfer | Masseteric nerve to free functioning muscle transfer. (Late no fibrillation on EMG) Receives: Procedure: Masseteric nerve to free functioning muscle transfer |
What is being measured
The primary outcome is the main question the study is designed to answer.
Comparing the outcomes on EFACE score
difference on the score
Measured: up to one year
Secondary outcomes (1)
Effect of addition of contracted growth factor around the anastomosis
time for nerve activation
Measured: up to one year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Oct 2022
- Study start4 Nov 2020
- Primary completion1 Jan 2023 (estimated)
- Study completion1 Apr 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Facial Nerve ParesisStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 24 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ahmed Mohamed Refaat Ahmed Abdelkarim, Assiut University
- Investigators
- Ahmed M refaat, mcch, Principal investigator, faculty of medcine assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05568108
- Sponsor's protocol ID
- Masseteric for facial nerve
- Status last verified
- Oct 2022
- First submitted
- 3 Oct 2022
- Last updated
- 6 Oct 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 6 Oct 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Using the Masseteric Nerve for Facial Nerve Reanimation: A Clinical Study.
- ClinicalTrials.gov ID
- NCT05568108
- Acronym / sponsor ID
- Masseteric for facial nerve
- Conditions
- Facial Nerve Paresis
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 24 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- 4 Nov 2020 (actual)
- Primary completion
- 1 Jan 2023 (estimated)
- Study completion
- 1 Apr 2023 (estimated)
- First posted
- 5 Oct 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The return of eyelid function and facial expression in Patients with facial nerve affection is very important for quality of life. Eyelid dysfunction leads to drying and ulceration of cornea which may lead to permanent vision loss.
Facial paralysis is distinguished into two main groups according to the presence or absence of facial fibrillations at needle Electromyography. Recent paralysis, mainly lasting less than two years generally show these signs and are eligible for reactivation of facial nerve by anastomosing it to a donor one (early facial reanimation).
The masseteric nerve (motor branch of trigeminal nerve ) is a reliable donor nerve on early facial reanimation So on this study we examine the advantages and disadvantages of using masseteric nerve to develop a protocol for use of facial reanimation and restoration of function on facial paresis.
Detailed description
Type of the study: observtional Study (clinical trial)
Intervention Model Description:
Patients will be two groups according to the surgical procedure performed as follows:
- Group A: masseteric nerve to central branch facial nerve. (Early fibrillation on EMG)
- Group B: Masseteric nerve to free functioning muscle transfer. (Late no fibrillation on EMG)
Allocation and Randomization:
Twenty-four patients will be assigned to Group A early or Group B late (2 groups). group A will be for early and be will be for late cases
Study Setting: Plastic and Reconstructive Surgery Department, Assuit University Hospital and San Paolo university hospital of Milano university.
Study subjects:
Inclusion criteria:
1.Facial nerve affection 2.Patients are generally fit with no other disease interfere with microsurgery. 3.Electromyography showing fibrillations for group A and no fibrillation for group B.
- Exclusion criteria:
1.Patient with other medical or mental disease-causing generalized paralysis. 2.Syndromic cases. 3.Patients are generally unfit or with any disease interfere with microsurgery.
- Sample Size Calculation: 24 Sample size was calculated using G power program version 3.1.9.4 (6) in order to detect a significant difference in mean of EFACE score (one of main assessed outcomes in the study ) between two groups under the study , assumed effect size 0.6 based on clinical assumption ( novel study ), α error 0.3 , power 0.80, and allocation ratio 1: 1.
Twenty-two patient plus 10% for dropouts to make total twenty-four (12 patient for every group).
Study tools
All patients in this study are subjected to:
Pre-operative Assessment:
- Patient history.
- All patients will do preoperative clinical and neurophysiological assessments of mimetic muscle function and donor nerve status (the ipsilateral deep temporal nerve. The neurophysiological tests will include needle Electromyography (EMG) for recruitment of residual motor unit action potential to determine which procedure
- The trigeminal motor component will be tested by palpating the temporalis muscle and masseteric muscle during chewing and via needle EMG to verify availability as a donor motor nerve.
- Photographic documentation preoperative using standardized EFACE view.
- Ophthalmological assessment of the affected eye for detection of redness, ulcer, etc.
Surgical procedure:
Group A the investigators will avoid the use of muscle relaxants to induce anaesthesia and employ an electro-stimulator to identify the masseteric nerve and the facial nerve branches supplying the affected side.
Exploration on the affected side a facelift-type incision will be performed, and an anterior subcutaneous flap is then will be lifted for several centimetres. In the inferior zygomatic region, the plane of elevation is deepened into the sub-SMAS plane and a composite flap elevated for several centimetres. Following elevation in this plane, the distal facial nerve branches will be identified. The distal portion of the zygomatic nerve is usually located midway between the oral commissure and the helical root. and was confirmed by nerve stimulator.
Then masseteric nerve identified in masseteric muscle and then end to end anastomosis with the central branch of facial nerve Then suction drain will be put and will be removed after 24 hours. Group B The same technique of face lift and harvest the free functioning muscle flap and micro anastomosis of the flap for the superficial temporal system or the facial artery system and the same technique for masseteric nerve identification and end to end anastomosis and to side for prepare cross nerve form the stage one Post-operative All patient will receive physiotherapy and post-operative follow up to detect any wound complication.
Evaluation (After 6 months from the operation)
- Photo documentation for EFACE
- Donor site morbidity.
- Onset of first movement
- Patient satisfaction
Complications:
- General surgical complication.
- General complication due to general anaesthesia.
- Specific complication:
- Delayed healing of nerve anastomosis.
- Affection of mastication.
- No postoperative improvement.
Research outcome measures:
- Primary (main): Comparing the outcomes on EFACE score
Secondary (subsidiary):
- Easy technique for rapid masseteric nerve identification.
- Effect of addition of contracted growth factor around the anastomosis
- Procedure-related morbidity and mortality.
- Effect of selective neurectomy for overactive affected branches with the total reanimation
- The experience of adding another neural impots with masseteric nerve
- Operative time and hospital stay.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| nerve transfer | – | Procedure: masseteric nerve to central branch facial nervemasseteric nerve to central branch facial nerve. (Early fibrillation on EMG) |
| nerve and free functioning muscle transfer | – | Procedure: Masseteric nerve to free functioning muscle transferMasseteric nerve to free functioning muscle transfer. (Late no fibrillation on EMG) |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Facial nerve affection patients
Key inclusion criteria (3 listed)
- Facial nerve affection
- Patients are generally fit with no other disease interfere with microsurgery.
- Electromyography showing fibrillations for group A and no fibrillation for group B.
Key exclusion criteria (3 listed)
- Patient with other medical or mental disease-causing generalized paralysis.
- Syndromic cases.
- Patients are generally unfit or with any disease interfere with microsurgery.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| masseteric nerve to central branch facial nervemasseteric nerve to central branch facial nerve. (Early fibrillation on EMG) | Procedure or surgery | nerve transfer |
| Masseteric nerve to free functioning muscle transferMasseteric nerve to free functioning muscle transfer. (Late no fibrillation on EMG) | Procedure or surgery | nerve and free functioning muscle transfer |
Primary outcome
Comparing the outcomes on EFACE score
Time frame: up to one year
difference on the score
1 secondary outcome
Effect of addition of contracted growth factor around the anastomosis
Time frame: up to one year
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Oct 2022.
- Individual participant dataSharing planned: Undecided
Related trials for Facial Nerve Paresis
RecruitingObservational study
Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies
Congenital Fibrosis of Extraocular Muscles, Duane Retraction Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ahmed M refaat, mcch principal investigator
faculty of medcine assiut University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Facial Nerve Paresis, run by Assiut University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 6 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Ahmed M refaat, MCCh (00201008022747, ahmed.abdelkarim@med.aun.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Comparing the outcomes on EFACE score (time frame: up to one year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2022.